I started my PhD project in the field of Genetics after finishing my studies in Biology at the University of Barcelona. During my PhD, I focused on elucidating the function of CERKL, an inherited retinal dystrophy gene, as well as the characterization of a knockout mouse model for this gene. After my PhD, I studied the contribution of Ubiquitin and Sumo signalling in the determination of photoreceptor cell fate at the University of Barcelona. In October 2012, I joined the group of Dr. Rob Collin at the Department of Human Genetics of the Radboudumc to investigate a promising antisense oligonucleotide (AON)-based therapy for one of the most recurrent mutations in CEP290 gene causing Leber congenital amaurosis. In the last years, I have been involved in expanding the use of these molecules to other eye diseases. Currently, I am starting my own group focused on on the design and assessment of new therapeutic approaches for inherited retinal disorders.